This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded
overfunded
DNApal
100%
Raised
£50,020
Investors
93
Target
£50,000
Equity
6.25%
Pre-money valuation
£750,000

Say goodbye to generic programmes and hello to personalised diet, health and fitness app, powered by your DNA. DNApal aims to combine DNA information with other factors like age, weight, diet, family history and health goals to help you achieve and maintain optimal health and wellbeing.

  • Global DNA diagnostics market expected to be worth $19bn by 2020 with10.2% annual growth
  • We can interpret data from two of the biggest players in the market
  • Won best pitch at VentureFest 2019 at Oxford Brookes University
  • Aiming to launch MVP January 2020 (iOS)

Idea

We believe diet, health & fitness programmes often fail because they ignore the fact that we are all unique. They lack the one thing that has the potential to radically improve health, performance, wellbeing & longevity - DNA information.

In 2014 the global DNA diagnostics market was estimated to be worth $19bn, & to reach over 20m people by 2020 - it has surpassed this prediction.

Two of the largest consumer DNA companies, 23andMe & Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies when entered by, & at the users discretion, allowing access to our information, recommendations & advice. We also offer our own proprietary DNA tests.

Combining DNA with personal data collected via the app, we plan to give precise recommendations on how to improve diet, weight loss, sleep, hormone balance, fitness & more. We are also aiming to recommend further testing & specific supplements where necessary & offer 1:1 consultations with a specialist. The information, recommendations & advice provided to users will be based on published research & our clinical experience.

We have self-funded the development to date & plan to start beta testing soon with the aim to launch our first MVP on iOS by January 2020.

We are looking for investment to help develop the full scope of the app, content & weekly goals & challenges to keep users committed.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the DNApal pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered? Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

DNApal has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Seed Enterprise Investment Scheme (SEIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 50 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.